Difficulty: Medium
Average Score: 73%
Testbank
The nurse is caring for a client in the hospital who is being treated for Hodgkin's disease and is taking a chemotherapeutic regimen in the hospital's oncology unit. When reviewing the client's medication history, what regimen does the nurse recognize as the drugs in the treatment of Hodgkin's disease?
Correct answer
B
Rationale
Doxorubicin, bleomycin, vinblastine, and dacarbazine are recognized as the standard chemotherapeutic agents used in the treatment of Hodgkin's disease.
This regimen, often referred to as ABVD, is effective in targeting the cancerous cells associated with Hodgkin's lymphoma, helping to reduce tumor size and improve patient outcomes. Each drug in this combination plays a specific role in disrupting cancer cell proliferation and enhancing treatment efficacy.
A: Ceftriaxone, furosemide, rifampin, ibuprofen are not used in the treatment of Hodgkin's disease; instead, they are antibiotics and supportive medications that do not address the underlying malignancy.
C: Albuterol, ipratropium, methylprednisolone, and acetylcysteine are primarily respiratory medications and corticosteroids, which do not form part of the chemotherapy regimen for treating Hodgkin's disease.
D: Enalapril, atenolol, verapamil, and lovastatin are cardiovascular and lipid-lowering agents that are not relevant to the treatment of Hodgkin's disease, as they do not have any therapeutic effect on cancer cells.
This regimen, often referred to as ABVD, is effective in targeting the cancerous cells associated with Hodgkin's lymphoma, helping to reduce tumor size and improve patient outcomes. Each drug in this combination plays a specific role in disrupting cancer cell proliferation and enhancing treatment efficacy.
A: Ceftriaxone, furosemide, rifampin, ibuprofen are not used in the treatment of Hodgkin's disease; instead, they are antibiotics and supportive medications that do not address the underlying malignancy.
C: Albuterol, ipratropium, methylprednisolone, and acetylcysteine are primarily respiratory medications and corticosteroids, which do not form part of the chemotherapy regimen for treating Hodgkin's disease.
D: Enalapril, atenolol, verapamil, and lovastatin are cardiovascular and lipid-lowering agents that are not relevant to the treatment of Hodgkin's disease, as they do not have any therapeutic effect on cancer cells.